Related Experiment Video
Updated: Jul 31, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Blastocystis sp.-An emerging cause of diarrhea post stem cell transplantation
Osman Radhwi1,2, Abdullah Almohammadi1,2, Adel Almarzouki1,2
1Hematology Department, Faculty of Medicine, King Abdulaziz University Hospital King Abdulaziz University Jeddah Saudi Arabia.
Key Clinical Message:
Protozoans are endemic in the Middle East and diarrhea workup post stem cell transplant should always include stool examination for ova and parasites.
Abstract:
We present a case of Blastocystis sp. infection in a multiple myeloma patient who developed diarrhea on day five of post-autologous stem cell transplantation. Diarrhea is a major complication and a potential cause of mortality in this population. Testing for endemic protozoan is recommended.
Insights
Protozoan infections like Blastocystis sp. are common after stem cell transplants, especially in the Middle East. Always test for parasites in transplant patients experiencing diarrhea to ensure timely diagnosis and treatment.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Hematology
Background:
- Stem cell transplantation is a life-saving procedure but carries risks of opportunistic infections.
- Diarrhea is a frequent and potentially life-threatening complication following stem cell transplantation.
- Protozoan infections are endemic in certain regions, including the Middle East.
Observation:
- A case of Blastocystis sp. infection is presented in a multiple myeloma patient.
- The patient developed diarrhea on day five post-autologous stem cell transplantation.
- Blastocystis sp. is a protozoan parasite that can cause gastrointestinal distress.
Findings:
- The patient's diarrhea was attributed to Blastocystis sp. infection.
- Early identification of parasitic infections is crucial in immunocompromised patients.
- Stool examination for ova and parasites is essential in the workup of diarrhea post-transplant.
Implications:
- Clinicians should consider endemic protozoan infections in the differential diagnosis of diarrhea in stem cell transplant recipients.
- Prompt diagnostic testing can prevent severe complications and mortality associated with opportunistic infections.
- Implementing routine stool examinations for ova and parasites can improve patient outcomes in this vulnerable population.
Related Concept Videos
Fungal Phylum Microsporidia
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Renewal of Intestinal Stem Cells
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

